| 09th week of 2021 patent applcation highlights part 9 |
| Patent application number | Title | Published |
|---|
| 20210059892 | PILLOW TYPE NECK MASSAGE DEVICE WITH ADJUSTABLE MASSAGE INTENSITY | 2021-03-04 |
| 20210059893 | HEADACHE THERAPEUTIC INSTRUMENT | 2021-03-04 |
| 20210059894 | PEBBLE BED SAUNA DEVICE | 2021-03-04 |
| 20210059895 | FULL BODY ROBOTIC MASSAGE SYSTEMS AND METHODS BODY STRETCHING | 2021-03-04 |
| 20210059897 | PERSONAL USE EXTRACORPOREAL LOW INTENSITY ACOUSTIC OR SHOCK WAVE MECHANICAL TIP AND METHODS OF USE | 2021-03-04 |
| 20210059898 | PERCUSSIVE THERAPY DEVICE | 2021-03-04 |
| 20210059899 | ANTEROPOSTERIOR THORACIC RESTRICTION DEVICE | 2021-03-04 |
| 20210059900 | DEVICES AND METHODS FOR ACTIVE DECOMPRESSION OF THE CHEST DURING CIRCUMFERENTIAL CONSTRICTION CARDIOPULMONARY RESUSCITATION | 2021-03-04 |
| 20210059901 | ION PULSE TREATMENT APPARATUS FOR EYES | 2021-03-04 |
| 20210059902 | CONTAINER FOR MEDICAL AND/OR PHARMACEUTICAL PRODUCTS WITH INTERSTICE | 2021-03-04 |
| 20210059903 | SYSTEMS AND METHODS FOR PORTABLE PILL DISPENSERS WITH VARIOUS DISPENSING MECHANISMS | 2021-03-04 |
| 20210059904 | PILL FEEDER | 2021-03-04 |
| 20210059905 | SYSTEMS AND METHODS FOR BIOIMPEDANCE BODY COMPOSITION MEASUREMENT | 2021-03-04 |
| 20210059906 | COMPOSITION OF TEMPORARY CROWN MATERIALS | 2021-03-04 |
| 20210059907 | OXIDATION DYEING PROCESS USING A SUBSTRATE BEARING AT LEAST ONE OXIDATION DYE, SEVERAL PRESERVATIVES AND AN OXIDIZING AQUEOUS COMPOSITION | 2021-03-04 |
| 20210059908 | ASSEMBLY CONTAINING AT LEAST ONE DYEING SUBSTRATE AND AT LEAST ONE SUBSTRATE COMPRISING ONE OR MORE PRESERVATIVES, DISPENSING MEANS, AND DYEING PROCESS | 2021-03-04 |
| 20210059909 | METHOD FOR PRODUCING COMPOSITION CONTAINING HARDLY WATER-SOLUBLE AROMATIC COMPOUND | 2021-03-04 |
| 20210059910 | DISPERSION OF FINE LIPID PARTICLE DISPERSION | 2021-03-04 |
| 20210059911 | SUNSCREEN COMPOSITION WITH A HIGH UV FILTER LOAD | 2021-03-04 |
| 20210059912 | SKIN CARE COMPOSITION FOR THE PERISTOMAL REGION | 2021-03-04 |
| 20210059913 | Aluminum-Free Antiperspirant / Deodorant Compositions | 2021-03-04 |
| 20210059914 | Zinc Phosphate Containing Compositions | 2021-03-04 |
| 20210059915 | COSMETIC COMPOSITION HAVING A LAMELLAR NETWORK | 2021-03-04 |
| 20210059916 | COSMETIC COMPOSITION FOR MAKEUP REMOVAL COMPRISING WATER-SOLUBLE SURFACTANT AND OIL-SOLUBLE SURFACTANT | 2021-03-04 |
| 20210059917 | COSMETIC COMPOSITION AND ITS USE, DERMOCOSMETIC FORMULATION | 2021-03-04 |
| 20210059918 | Oral Care Compositions Having Increased Foam Production and Methods for the Same | 2021-03-04 |
| 20210059919 | PLANT ACTIVES AND THEIR ANTI-POLLUTION EFFECTS THEREOF | 2021-03-04 |
| 20210059920 | Minoxidil Adjuvant Therapies | 2021-03-04 |
| 20210059921 | SILICONE-FREE, LOW-FRICTION CLEANSER WITH HIGH-FOAMING PROPERTIES | 2021-03-04 |
| 20210059922 | HAIR TREATMENT COMPOSITIONS CONTAINING PECTIN AND CATIONIC COMPOUNDS | 2021-03-04 |
| 20210059923 | ANTI-STAIN ORAL CARE COMPOSITION | 2021-03-04 |
| 20210059924 | BIO-BASED AND BIODEGRADABLE ELASTOMER FOR COSMETIC AND PERSONAL CARE | 2021-03-04 |
| 20210059925 | HAIR CONDITIONING PRODUCT COMPRISING FIRST AND SECOND COMPOSITIONS | 2021-03-04 |
| 20210059926 | PACKAGED HAIR CARE COMPOSITION | 2021-03-04 |
| 20210059927 | COSMETIC COMPOSITION COMPRISING DENDROBIUM CANDIDUM FLOWER EXTRACT | 2021-03-04 |
| 20210059928 | METSCHNIKOWIA REUKAUFII EXTRACT AND USE IN COSMETICS | 2021-03-04 |
| 20210059929 | COSMETIC ACTIVE SUBSTANCE OBTAINED THROUGH BIOCONVERSION BY LACTOBACILLUS ARIZONENSIS OF ITS ORIGINAL SUBSTRATE, METHOD FOR OBTAINING SAME COMPOSITION COMPRISING SAME, AND USES | 2021-03-04 |
| 20210059930 | USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION | 2021-03-04 |
| 20210059931 | METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA | 2021-03-04 |
| 20210059932 | Multi-layer edible strip containing active medicinal ingredients | 2021-03-04 |
| 20210059933 | HYDROGELS AS ORAL DELIVERY DOSAGE FORMS, METHODS OF MAKING AND USING SAME | 2021-03-04 |
| 20210059934 | METHODS AND COMPOSITIONS FOR TREATING DIABETIC FOOT ULCERS | 2021-03-04 |
| 20210059935 | SELF-EMULSIFYING NANO-EMULSIONS | 2021-03-04 |
| 20210059936 | COLLAGENASE LOADED LIPOSOMES FOR ENHANCING DRUG DELIVERY | 2021-03-04 |
| 20210059937 | Liposome Formulation of Fluticasone Furoate and Method of Preparation | 2021-03-04 |
| 20210059938 | Nanostructure Enhanced Targeting (NSET) of Inflammatory Cells | 2021-03-04 |
| 20210059939 | Hydrophobic Molecule-Induced Branched Polymer Aggregates and their Use | 2021-03-04 |
| 20210059940 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | 2021-03-04 |
| 20210059941 | METHODS AND DEVICES FOR TREATING A RETINAL DETACHMENT | 2021-03-04 |
| 20210059942 | COMPOSITIONS AND METHODS OF TREATING THERAPY RESISTANT CANCER AND USES THEREOF | 2021-03-04 |
| 20210059944 | NOVEL DOSAGE FORM | 2021-03-04 |
| 20210059945 | Oral Drug Delivery System and Method for Fabricating Thereof | 2021-03-04 |
| 20210059946 | INTRAMUSCULAR DEPOT OF DECOQUINATE COMPOSITIONS AND METHOD OF PROPHYLAXIS AND TREATMENT THEREOF | 2021-03-04 |
| 20210059947 | METHOD FOR PRODUCING FREEZE-DRIED FORMULATION | 2021-03-04 |
| 20210059948 | CYCLIC ORALLY DISINTEGRATING TABLET | 2021-03-04 |
| 20210059949 | MODIFIED RELEASE COMPOSITION COMPRISING A CANNABINOID | 2021-03-04 |
| 20210059950 | PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN | 2021-03-04 |
| 20210059951 | VACCINE TREATMENT AND CONTROL INFECTIOUS AGAINST VIRAL PATHOGENS UTILIZING HEPARAN SULFATE (HS) AS CELLULAR RECEPTOR | 2021-03-04 |
| 20210059952 | NANOPARTICLES FOR TREATMENT OF POSTERIOR SEGMENT OCULAR DISEASES AND CONDITIONS | 2021-03-04 |
| 20210059953 | LIPID NANOPARTICLE FORMULATIONS OF NON-VIRAL, CAPSID-FREE DNA VECTORS | 2021-03-04 |
| 20210059955 | SYSTEMS AND METHODS FOR DECRYSTALLIZATION OF URIC ACID | 2021-03-04 |
| 20210059956 | PERCUTANEOUS ABSORPTION PREPARATION FOR TREATING DEMENTIA COMPRISING DONEPEZIL | 2021-03-04 |
| 20210059957 | TRANSDERMAL DEVICE COMPRISING PAIN MOLECULES | 2021-03-04 |
| 20210059958 | Enhanced Moisturizing Lotion Compositions | 2021-03-04 |
| 20210059959 | USE OF CANNABINOIDS IN THE TREATMENT OF MENTAL DISORDERS | 2021-03-04 |
| 20210059960 | PHARMACEUTICAL COMPOSITION COMPRISING A CANNABINOID | 2021-03-04 |
| 20210059961 | CANNABINOID DOSING REGIME FOR ACNE | 2021-03-04 |
| 20210059962 | STIMULATION OF T REGULATORY CELLS BY CANNABIDIOL AS A MEANS OF TREATING ARTHRITIS AND AUTOIMMUNITY | 2021-03-04 |
| 20210059963 | Beta-blockers for treating and/or preventing pathological scars | 2021-03-04 |
| 20210059964 | Anti-I-Type Allergy Agent, Degranulation Inhibitor for Basophils and Mast Cells, Anti-Dementia Agent, Agent for Improving/Inhibiting Short-Term Memory Impairment | 2021-03-04 |
| 20210059965 | ORAL BACLOFEN SOLUTIONS | 2021-03-04 |
| 20210059966 | NEPRILYSIN INHIBITORS | 2021-03-04 |
| 20210059967 | LIQUID PARENTERAL COMPOSITIONS OF LEVOTHYROXINE | 2021-03-04 |
| 20210059968 | LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE | 2021-03-04 |
| 20210059969 | ALPHA-AMINOADIPATE FOR TREATMENT OF VISION LOSS AND RESTORING SIGHT | 2021-03-04 |
| 20210059970 | NUTRITIONAL SUPPLEMENTS AND METHODS OF NUTRITIONAL SUPPLEMENTATION AFFECTING MENTAL WELLNESS AND/OR MOOD | 2021-03-04 |
| 20210059971 | PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN | 2021-03-04 |
| 20210059972 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | 2021-03-04 |
| 20210059973 | Treatment of Affective Disorders | 2021-03-04 |
| 20210059974 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2021-03-04 |
| 20210059975 | Formulated Cannabis Oil Powder By Nanoemulsifycation, Methods Of Producing And Uses Thereof | 2021-03-04 |
| 20210059976 | ORAL PHARMACEUTICAL FORMULATION COMPRISING CANNABINOIDS AND POLOXAMER | 2021-03-04 |
| 20210059977 | COMBINATION THERAPIES FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS | 2021-03-04 |
| 20210059978 | TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND USES THEREOF IN THE TREATMENT OF INFECTIOUS CONDITIONS | 2021-03-04 |
| 20210059979 | TOPICAL COMPOSITIONS FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS | 2021-03-04 |
| 20210059980 | OCULAR DRUG DELIVERY SYSTEM AND USES THEREOF | 2021-03-04 |
| 20210059982 | Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders | 2021-03-04 |
| 20210059983 | METHODS AND MATERIALS FOR IDENTIFYING AND TREATING CANCER | 2021-03-04 |
| 20210059984 | METHOD AND COMPOSITION FOR REVERSING COGNITIVE IMPAIRMENTS AND LOSS USING SGLT2 INHIBITORS | 2021-03-04 |
| 20210059985 | METHOD FOR PREVENTING AND/OR TREATING AGING-ASSOCIATED COGNITIVE IMPAIRMENT AND NEUROINFLAMMATION | 2021-03-04 |
| 20210059986 | TOPICALLY ADMINISTRABLE FORMULATION FOR THE CONTROL AND PREVENTION OF ANIMAL PARASITES | 2021-03-04 |
| 20210059987 | COMPOSITION OF AMINOPYRAN DERIVATIVE | 2021-03-04 |
| 20210059988 | PHARMACEUTICALLY ACCEPTABLE SALTS OF [3-(4- {2-BUTYL-1-[4-(4-CHLORO-PHENOXY)-PHENYL]-1H-IMIDAZOL-4-YL} -PHENOXY)-PROPYL]-DIETHYL-AMINE | 2021-03-04 |
| 20210059989 | COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101 | 2021-03-04 |
| 20210059990 | METHODS AND DRUG COMPOSITIONS FOR TREATING LYME DISEASE | 2021-03-04 |
| 20210059991 | TETRAHYDRO-1H-PYRIDO [3,4-b]INDOLE ANTI-ESTROGENIC DRUGS | 2021-03-04 |
| 20210059992 | HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS | 2021-03-04 |
| 20210059993 | COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS | 2021-03-04 |
| 20210059994 | USE OF I-BRD9 OR DERIVATIVES THEREOF IN PREPARING ANTI-EPILEPTIC DRUGS | 2021-03-04 |
| 20210059995 | Composition for Protecting Cornea | 2021-03-04 |
